Pharmaceutical Client Seeks Assistance in Prioritizing Its Nanotechnology R&D Strategy

After surveying the shifting pharmaceutical technology landscape, the multinational pharmaceutical company sought a strategy and roadmap to help guide its future development efforts. In response, IBM proposed a two-part process. First, IBM Research, working together with GBS, leveraged IBM's existing nanotechnology research and extensive in-house expertise to provide a framework to guide the process. The GBS Strategy and Change team then used IBM's Business Insights Workbench (BIW) tool, VentureSource, and a host of other third party research to search for existing pharmaceutical nanotechnology-related patents, VC funding, global government and academic funding, publications, and commercialized and pipeline drugs using nanotechnology.